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Abstract: Blood analogues have long been a topic of interest in biofluid mechanics due to the 
safety and ethical issues involved in the collection and handling of blood samples. Although the 
current blood analogue fluids can adequately mimic the rheological properties of blood from a 
macroscopic point of view, at the microscopic level blood analogues need further development 
and improvement. In this work, an innovative blood analogue containing giant unilamellar 
vesicles (GUVs) was developed to mimic the flow behavior of red blood cells (RBCs). A natural 
lipid mixture, soybean lecithin, was used for the GUVs preparation, and three different lipid 
concentrations were tested (1 × 10−3 M, 2 × 10−3 M and 4 × 10−3 M). GUV solutions were prepared by 
thin film hydration with a buffer, followed by extrusion. It was found that GUVs present diameters 
between 5 and 7 µm which are close to the size of human RBCs. Experimental flow studies of three 
different GUV solutions were performed in a hyperbolic-shaped microchannel in order to measure 
the GUVs deformability when subjected to a homogeneous extensional flow. The result of the 
deformation index (DI) of the GUVs was about 0.5, which is in good agreement with the human 
RBC’s DI. Hence, the GUVs developed in this study are a promising way to mimic the mechanical 
properties of the RBCs and to further develop particulate blood analogues with flow properties 
closer to those of real blood. 
Keywords: blood analogues; Giant Unilamellar Vesicles; deformation index; in vitro blood; 
biomimetic; microcirculation 
 
1. Introduction 
Blood is one of the most important human biofluids as it is an essential element for different 
body functions contributing to homeostasis. This complex fluid transports multiple substances 
important for the cellular tissue and organs of the human body [1].  
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For most blood studies, mainly rheological blood analogues are used because they have 
physical properties close to those of blood, such as viscosity, density, and refractive index [2]. The 
present study aims to contribute to the improvement in the knowledge of blood flow in arterioles 
and capillaries and the development of blood analogue fluids for in vitro blood experiments. Blood 
analogue fluids are extremely relevant, as working with real blood continues to have ethical, 
economical, and safety barriers. In fact, the development of blood analogue fluids continues to draw 
much attention from researchers around the world who are working to mimic the physical and 
rheological properties of real blood [1–7].  
In the past, several blood flow studies were performed with Newtonian blood analogues 
composed of mixtures of glycerol and water [8–11]. Other studies have developed non-Newtonian 
fluids composed by xanthan gum or/and polyacrylamide diluted in glycerin and/or water [1,12]. 
However, in vitro blood experiments have found that it is crucial to take into account the cellular 
blood components that exist within the base fluid [13,14]. Pinto et al. [13], by performing 
experiments with in vitro blood samples, have observed a cell-free layer immediately downstream 
of a convergence bifurcation. Note that this physiological phenomenon does not happen with blood 
analogue fluids without solid elements, such as microparticles and microcapsules. 
One of the major challenges in developing blood analogues is to incorporate cellular-like 
components able to perform fundamental functions, such as the transport of gases and nutrients, 
and the ability to deform under flow when they pass through a narrower capillary. Thus, one can 
not only think on the development of a fluid as a whole; it is also necessary to focus our attention on 
the cellular elements present in human blood and try to mimic the blood cells experimentally. 
Recent experimental works [5,15] developed blood analogue fluids containing polystyrene and 
polymethylmethacrylate particles in order to mimic the flow of Red Blood Cells (RBCs). However, 
these particles present a major drawback, which is their rigidity, and when they are flowing within 
microchannels, they do not deform in the same way as the RBCs. To overcome this limitation, the 
development of solid suspended elements able to mimic the rheological behavior of human RBCs is 
essential. In order to achieve this objective, an innovative blood analogue fluid containing giant 
unilamellar vesicles (GUVs) [16,17] was developed to mimic the flow of RBCs in microchannels. 
Giant unilamellar vesicles are simple membrane systems that are important in the study of more 
complex biological membranes; they contain heterogeneities in lipid composition, shape, chemical, 
and mechanical properties [18]. The GUV’s size (1–100 µm) and their geometry enable us to perform 
individual flow visualizations by means of an optical microscope, and as a result they have been 
applied in several biophysical contexts where membrane composition, tension, and geometry can be 
controlled and/or manipulated by using microscopic systems [18]. Here, the GUVs were prepared 
using a natural lipid mixture (soybean lecithin) by hydration of a lipid film, followed by extrusion 
through polycarbonate membranes, to guarantee a uniform vesicles diameter. 
The main objective of this work is to develop an aqueous fluid containing GUVs with 
dimensions and mechanical properties similar to those of human RBCs. To investigate the ability of 
the GUVs to deform, flow measurements were performed in a microchannel with a hyperbolic 
constriction. Additionally, a rheological investigation of the proposed analogue fluid was performed 
by using a stress-controlled rheometer. 
2. Materials and Methods 
2.1. Preparation of GUVs 
Giant unilamellar vesicle (GUV) aqueous dispersions were prepared using a natural lipid 
mixture, soybean lecithin (Sternchemie, Hamburg, Germany), through a lipid thin-film hydration 
method, as described [16]. All reagents used for the preparation of GUVs using the lipid film 
hydration are shown in Table 1.  
It has been reported that giant unilamellar vesicles are relatively stable over a period of weeks, 
at proper storage conditions (~4 C) [19]. Tamba et al. [20], in a deep investigation focusing on the 
stability of this type of structure, showed that GUVs’ membranes in the liquid-ordered phase were 
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stable and no leakage of encapsulated molecules occurred, even in the presence of a high 
concentration of Triton X-100, a well-known membrane disruption agent.  
Table 1. Reagents for the giant unilamellar vesicle (GUV) preparation by using the lipid film 
hydration method. 
Compound 
Chemical 
Formula 
Molecular 
Weight 
(g mol−1) 
Purity Manufacturer 
Soybean lecithin C42H84NPO9 776.00 N.A. * 
Sternchemie (Hamburg, 
Germany) 
Chloroform CHCl3 119.38 99.8% 
Sigma-Aldrich® (St. Louis, 
MO, USA) 
Trizma® base C4H11NO3 121.14 99.9% 
Sigma-Aldrich® (St. Louis, 
MO, USA) 
Nile Red C20H18N2O2 318.37 N.A.* 
Sigma-Aldrich® (St. Louis, 
MO, USA) 
* N.A.: Not available. 
First, a Tris-HCl buffer solution was prepared in a 250 mL volumetric flask, with 0.3025 g of 
Trizma® Base (Sigma-Aldrich Inc., St. Louis, MO, USA) and ultrapure water (deionized water 
Millipore, Milli-Q grade, MilliporeSigma, St. Louis, MO, USA) to the final volume. A basic solution 
(pH around 10) was obtained, and then the pH was lowered to 7.4, using a hydrochloric acid 
solution. At the end, the buffer solution was stored in a glass flask. 
In this method, three solutions of GUVs were prepared, with final lipid concentrations of C1 = 1 
× 10−3 M, C2 = 2 × 10−3 M, and C3 = 4 × 10−3 M. For this purpose, the required amount (266 μL, 533 μL 
and 1066 μL) of a 5 × 10−2 M stock solution of soybean lecithin in chloroform was placed in a glass 
tube and dried under an ultrapure nitrogen stream, until a lipid film has formed. Then, 8 mL of the 
buffer solution previously prepared was added to the lipid film. The solutions thus obtained were 
placed in an ultrasonic bath (Branson 320) for 2 min, until a homogeneous dispersion was obtained. 
Then, three cycles of extrusion through polycarbonate membranes of 8-µm pore size were carried 
out (Extruder model: LIPEX™ 10 from Northern Lipids, Northern Lipids Inc., Burnaby, BC, Canada) 
using a pressure of 1.5 bar to improve size uniformity. A low pressure was applied to prevent 
bursting of the GUVs. Finally, the lipid dye Nile Red was added to the solutions to improve 
visualization of GUVs through microscopy. An ethanolic solution of Nile Red (2 × 10−3 M) was used.  
2.2. Microscopy System, Geometry, and Dimensions of the Microchannel  
In this work we have used a high-speed microscopy system composed by a high-speed camera 
(Fastcam SA3, Photron, Tokyo, Japan), an inverted microscope (IX71, Olympus, Tokyo, Japan), a 
syringe pump (Harvard Apparatus PHD ULTRA, Holliston, MA, USA), and a syringe with a 
volume of 10 mL (Terumo, Tokyo, Japan).  
The GUVs’ flow measurements were performed in a microchannel with a hyperbolic 
constriction followed by a sudden expansion. This geometry is widely employed to perform 
separation of blood cells from plasma and to assess changes in cell deformability, due to its ability to 
achieve a controlled extensional flow at the center of the microchannel contraction and to measure 
large numbers of cells in one single run [5,21,22]. 
A soft-lithography technique was used to fabricate the microfluidic device. The length of the 
hyperbolic contraction region (C) was 600 µm, the width of the microchannel (L) was 400 µm, and 
the contraction width was 15 µm (see detail in Figure 1). Note that all microchannels have a depth of 
about 15 µm. 
2.3. Image Analyses 
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After the images were obtained through an inverted microscopy system combined with a 
high-speed camera, image analysis was performed using the ImageJ® software (Version 1.52i). 
Several measurements were made within the fabricated microchannels, such as GUVs’ volume 
fraction, diameter, and deformation. 
2.4. Volume Fraction and Diameter of GUVs 
To obtain the volume fraction of the produced GUVs for each concentration, images were first 
processed by using several functions from ImageJ. To perform these measurements, a section of the 
channel was selected to carry out the study, as can be observed in Figure 1. 
 
Figure 1. Equipment used for the measurement and visualization of the flows: (a) inverted 
microscope; (b) high-speed camera; (c) syringe pump. In addition, in the upper right side there is an 
image obtained through ImageJ software of the volume fraction of GUVs, where W = 200 µm and L= 
200 µm. Main dimensions of the hyperbolic microchannel are shown at the detailed image 
To determine the volume fraction of GUVs for each concentration, images were processed by 
using the ImageJ software. Briefly, the original video was first converted to a stack of images and 
then a background image was created containing static objects, such as microchannel walls and 
GUVs attached on the walls. This procedure was used to eliminate all the static objects and as a 
result only the flowing GUVs were measured. The images were then filtered and treated and the 
grey scale images were converted to binary images, adjusting the threshold level in order to obtain, 
at the end, images containing GUVs as black edged ellipsoidal objects against a white background 
(see Figure 1). After this segmentation process and by using the Wand and Measure functions, we 
were able to measure the area and diameter of all the flowing GUVs (see Figure 1). The following 
equation was used to calculate the GUVs’ volume fraction:  
𝑉𝑜𝑙𝑢𝑚𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (%) =
𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝐺𝑈𝑉𝑠
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑒𝑙𝑒𝑐𝑡𝑒𝑑 𝑠𝑒𝑐𝑡𝑖𝑜𝑛
× 100 (1) 
where the total volume of GUVs corresponds to the volume of all the GUVs located at a selected 
region, and volume of the selected section corresponds to W × L × depth of the microchannel (see 
Figure 1). Note that all GUVs were considered as perfect spheres.  
2.5. Deformation of GUVs 
To perform deformability studies, the GUVs solutions C1, C2, and C3 were tested in a 
microfluidic device with a hyperbolic-shaped contraction. This kind of geometry has the ability to 
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measure the degree of deformation of flowing objects under a controlled homogeneous 
extensional-flow field. By using this geometry, several studies have successfully measured red blood 
cells [21–23], white blood cells [24], and rigid particles [15]. Hence, in this study, we decided to use 
this geometry in order to assess the GUVs’ deformability under three different flow rates, i.e., 1, 5, 
and 10 μL/min. After the image acquisition by using a high-speed video microscopy system, the 
images were processed in a similar way to the procedure used to measure the area and diameter of 
the GUVs. Figure 2 shows two treated images, at two consecutive frames, for the solution C1 at a 
flow rate of 5 μL/min, flowing through the hyperbolic contraction. In Figure 2a, it possible to observe 
that the GUV elongates when it is inside the contraction due to the high extensional flow, whereas in 
Figure 2b the GUV returns close to its original shape at rest (circular shape) due to the low shear 
flow that the GUV is submitted to at this region of the microchannel. 
 
Figure 2. Images obtained through the ImageJ software to study the deformation of GUVs: (a) GUV 
within the hyperbolic contraction; (b) GUV at the expansion region. These images correspond to the 
solution C1 at a flow rate of 5 μL/min. 
To investigate the deformation of GUVs flowing along the microchannel, the major (𝑀𝑎𝑗𝑜𝑟) and 
minor (𝑀𝑖𝑛𝑜𝑟) dimensions of the GUVs were measured in order to calculate their deformation index 
(𝐷𝐼) by using the following equation:  
𝐷𝐼 =
(𝑀𝑎𝑗𝑜𝑟 − 𝑀𝑖𝑛𝑜𝑟)
(𝑀𝑎𝑗𝑜𝑟 + 𝑀𝑖𝑛𝑜𝑟)
 (2) 
where 𝑀𝑎𝑗𝑜𝑟 and 𝑀𝑖𝑛𝑜𝑟 correspond to the major and minor axis lengths of the ellipse that can be 
best fitted to the GUVs. Note that the DI values are between 0 and 1, i.e., 0 corresponds to a perfect 
circle and higher values mean more deformed shapes. 
2.6. Rheological Characterization 
The rheological characterization of the GUV solutions was performed by a stress control 
rheometer (Bohlin CVO, Malvern, Worcestershire, UK) using a cone-plate geometry with a diameter 
of 55 mm and an angle of 1. The gap size for this geometry was 0.03 mm. The steady shear viscosity 
curves for all GUV solutions were obtained in a range of shear rates above 10 until 10000 s−1. The 
same test was performed with a blood sample of 5% hematocrit (Hct) in a saline solution [5,15,25]. 
All tests were carried out at a temperature of 22 ± 1 °C, corresponding to the room temperature 
verified during the performance of the flow studies. In addition, the minimum torque line [26], that 
represents the lower limit of the equipment, was added to the data in order to be considered for 
accurate measurements.  
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3. Results and Discussion 
3.1. Volume Fraction of GUVs 
The volume fraction of the GUVs obtained for each of the solutions with different 
concentrations is shown in Table 2. By analyzing this table, it can be concluded that, as expected, 
there is an increase in the volume fraction of GUVs with increasing concentration of the lipid 
mixture. However, the increase in volume fraction is not proportional to the rise in concentration, 
indicating that other factors, like the variation in GUV size, are likely to influence the volume 
fraction of GUVs. In fact, each GUV contains a large number of lipid molecules, and a relatively 
small variation in GUV diameter may have significant influence in the number of lipid molecules 
per vesicle. Moreover, high lipid concentrations may promote the formation of bilayer fragments in 
solution, with a decrease in the volume fraction of GUVs present in the solution. 
Table 2. Volume fraction of GUVs at different concentrations. 
Concentration (M) Volume Fraction (%) 
1 × 10−3 1.6 
2 × 10−3 2.1 
4 × 10−3 2.5 
3.2. Diameter of GUVs 
Figure 3 shows the diameters of the GUVs obtained for each of the solution concentrations. As 
can be seen in Figure 3, for all concentrations, there are a high number of GUVs with diameters 
between 5 and 7 µm. These results show that the proposed protocol allows for the production of 
GUVs with sizes close to those of the RBCs, since human RBCs have diameters between 6 and 9 µm 
[27]. Additionally, these results indicate that the higher the lipid concentration in solution is, the 
lower are the average diameters of the GUVs and the higher is the dispersity in size values. Thus, the 
solution that contains GUVs closest in terms of size with human RBCs is the one with the lower 
lecithin concentration, i.e., solution C1 (1 × 10−3 M). 
 
Figure 3. Diameter of GUVs. (a) Solution C1; (b) Solution C2; (c) Solution C3. 
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3.3. Deformation of GUVs 
The study of the GUVs’ deformability was performed in seven different regions along the 
microchannel, as can be seen in Figure 4. The deformation of the GUVs was investigated for the 
developed solutions (C1, C2, and C3) at three different flow rates, i.e., 1, 5, and 10 μL/min. Note that 
at each flow rate we measured about 500 GUVs, i.e., for each region we measured the DI of at least 70 
GUVs.  
From Figure 4, it can be observed that the GUVs have the ability to deform in the region of the 
hyperbolic contraction and, as expected, the DI increases as the flow rate rises. The GUVs upstream 
of the contraction have a DI close to zero, mostly due to the low shear rate. However, as they 
approach the hyperbolic contraction, the GUVs’ DI increases significantly. After the contraction, this 
index decreases until it returns to values close to zero. These results are extremely promising, since 
GUVs, similarly to RBCs, have the ability to deform under strong extensional flows.  
 
Figure 4. Deformation index (DI) of GUVs along the microchannel for the solution C1 (1 × 10−3 M) 
and for the flow rates Q1 = 1 μL/min, Q5 = 5 μL/min, and Q10 = 10 μL/min. 
Recently, Pinho and colleagues [15] measured the DI of human RBCs with geometry and flow 
conditions similar to the ones used in this study. They measured the DI of human RBCs at a 
hyperbolic contraction region of about 0.36 for a flow rate of 5 μL/min (see Figure 5). For the same 
flow rate, the values of the GUVs’ DI obtained in this study were about 0.48, which are in reasonable 
agreement with the human RBCs’ DI. Additionally, in Figure 5 it is possible to observe that the 
results were in closer agreement at the downstream region of the contraction where the cells and 
GUVs tend to recover to their original shape. Hence, it is evident that the GUVs produced in this 
study are a promising way to mimic the mechanical properties of the RBCs and, consequently, to 
develop blood analogues with flow properties closer to real blood. 
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Figure 5. Deformation index (DI) of GUVs (C1) and human red blood cells (RBCs) at different 
microchannel regions with a flow rate of 5 μL/min. 
3.4. Rheology of GUVs 
To perform the rheology study, the three proposed solutions, C1, C2, and C3, were analyzed by 
using a stress-controlled rheometer. In this study, a small amount of each solution was placed below 
the cone-plate geometry and all the shear flow curves were obtained at a temperature of about 22 °C. 
Figure 6 shows the rheological results for the three developed solutions. Analyzing Figure 6, it can 
be observed that the three solutions have a similar viscosity. However, a slight increase with the 
increment of the concentration of soybean lecithin was observed. 
 
Figure 6. Viscosity of the proposed GUV solutions: viscosity as a function of shear rate. The dashed 
line represents the minimum torque line of the equipment. 
More evidence from Figure 6 is that the viscosity of the three solutions of GUVs is close to the 
viscosity of water, which is 0.0010002 Pa·s at a temperature of 20 °C. This result was expected, since 
the medium of GUV solutions is an aqueous buffer solution (main component is ultrapure water). 
Next, we decided to perform a rheological comparison between the solution C1 and a sample with 
5% hematocrit in saline solution (see Figure 7).  
The results from Figure 7 show that the solution C1 has a viscosity close to the 5% haematocrit 
in a saline solution. Thus, this comparison shows that the blood analogue proposed in this work is in 
close agreement with rheological behavior of in vitro blood samples having low Hcts. These kind of 
samples are widely used to determine the rate of deformability of different cell types, such as 
healthy cells, cells infected with the malaria parasite, and cancer cells [21,28,29].  
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Figure 7. Viscosity of the solution of GUVs C1 and 5% Hct in saline solution. 
4. Limitations and Future Directions 
In this study, low concentrations of GUVs were used in order to better follow individual GUVs 
and measure their deformability along the hyperbolic microchannel. By using high concentrations, it 
is extremely difficult to follow the behavior of individual GUVs, as most of the time the GUVs are 
surrounded by neighboring GUVs. For larger Htcs, it is well known that in microcirculation there is 
a formation of a cell-free layer around the microvessel walls. In this way, we also performed 
measurements with samples having high concentrations of GUVs. However, in contrast to the RBCs, 
the GUVs were extremely difficult to visualize and as result the cell free layer measurements need to 
be improved in the near future. The visualization of GUVs can be improved by two different 
approaches: 
- Fluorescent water-soluble dyes (e.g., Rhodamine B, fluorescein) can be encapsulated into GUVs 
to color their aqueous inner compartment (a size exclusion chromatography will allow the 
separation of the non-encapsulated dye molecules); 
- Phospholipids labelled with fluorescent molecules (e.g., with Rhodamine B, dansyl, or cyanine 
dyes) can be included in GUVs’ formulations to more effectively color the lipid bilayer. 
The GUVs deformability, when compared with human RBCs, indicates that GUVs need to be 
slightly less deformable. Hence, to increase GUVs rigidity, the use of lipids with a high melting 
transition temperature, Tm, in GUVs’ composition could be a solution. These lipids are in the rigid 
gel phase at room temperature, causing a decrease in fluidity of the lipid bilayer. Considering that 
phosphatidylcholines are the most abundant lipids in biological membranes, the lipids DPPC 
(dipalmitoylphosphatidylcholine), with Tm = 41 C [30], or DSPC (distearoylphosphatidylcholine, Tm 
= 55 C [30]) might be a good choice. Another possibility is the inclusion of cholesterol, which 
promotes the formation of an ordered liquid phase in the lipid bilayer when it is in the fluid 
disordered state [31], enhancing the mechanical stability of the membrane [32]. A different strategy, 
consisting of the inclusion of magnetic nanoparticles in the GUVs’ formulation (forming magnetic 
GUVs), could also be attempted. It has been reported that magnetic nanoparticles tend to aggregate 
in membranes of liposomes and cells [33], and this effect could be explored to increase the rigidity of 
the GUVs’ lipid bilayer.  
5. Conclusions 
The main objective of this work was to develop a particulate blood analogue fluid based on 
GUVs, with their mechanical properties comparable to RBCs flowing in microchannels. 
In this work, the volume fraction was determined for three solutions of GUVs (from natural 
soybean lecithin), differing from one another by the lipid concentration. It has been observed that the 
higher the amount of lecithin, the higher the GUVs’ volume fraction in the fluid. Regarding GUVs 
diameters, it was found that in all solutions, the GUVs size varied between 5 and 7 µm, which is 
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close to the size of human RBCs. In addition, it was found that the higher the concentration of 
soybean lecithin, the lower the average diameter of GUVs, together with the larger dispersity in size 
values. 
Experimental measurements of the produced GUVs flowing through hyperbolic-shaped 
microchannels have shown not only that the GUVs had the highest deformation at the end of the 
contraction region, due to the strong extensional flow, but also the GUVs’ DI increased with the 
increasing flow rate. Additionally, when the GUVs were subjected to a strong extensional flow, it 
was found that GUVs’ DIs were about 0.36, which are in reasonable good agreement with the human 
RBCs’ DI. These results make them a promising candidate to mimic the RBCs’ mechanical properties 
and, consequently, to develop particulate solutions with flow properties analogous to real whole 
blood. 
Regarding rheological behavior, the GUV solutions have shown similar viscosities for all the 
tested concentrations. Nevertheless, a slight increase with lipid concentration was observed. The 
solution 1 × 10−3 M in lecithin revealed a viscosity similar to the one of a 5% Hct in saline solution.  
Generally, the results obtained in this work clearly indicate that the introduction of giant 
unilamellar vesicles into non-particulate blood analogue fluids may enable a better mimicking of 
real blood. In future studies will likely involve testing some modifications on lipid composition, 
surface charge, and preparation methods, to advance towards a blood analogue fluid that fully 
mimics all blood cell components and flow behavior. 
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